Treatment of sepsis

摘要

Your Editorial1 emphasises the substantial burden of sepsis worldwide and the disappointing absence of specific drugs to treat it. Development of such new treatments is crucial; however, most of the estimated 15-19 million cases of sepsis globally are in low-income and middle-income countries,2 which are home to more than 80% of the world's population. Because of the scarcity of many basic necessities that are needed for the provision of medical care in many low-resource settings, novel treatments for sepsis are unlikely to become available to much of the world for many years.